rose Tuesday after the medical device maker said fourth-quarter earnings might top its previous guidance, thanks to record revenue in the period.
The Natick, Mass.-based company expects earnings for its fourth quarter ended Dec. 31 to be within or slightly above its October forecast of 14 cents to 16 cents a share, excluding items. The Thomson First Call consensus estimate is 16 cents a share.
Boston Scientific also said preliminary net sales for the quarter rose to a record $939 million, about 15% higher than the year-ago period. That included $57 million that the company attributed to the weak dollar.
Recently, shares were up 60 cents, or 1.6%, to $37. The company had a 2-for-1 stock split that took effect in November.
The company will release final fourth quarter and full-year 2003 earnings on Feb. 2.